A new collaboration aims to develop VMX-C001 to treat severe bleeding in patients on anticoagulants, targeting a 2029 …
A new collaboration aims to develop VMX-C001 to treat severe bleeding in patients on anticoagulants, targeting a 2029 …
Early results from a multi-centre trial indicate that BI-8721 may slow cognitive decline and reduce amyloid biomarkers in …
Interim data in osteogenesis imperfecta show safety remains acceptable, but efficacy thresholds for early stopping were not met
Major change in NIH policy mandates inclusion of organoids, computational models, or other non-animal methods in proposals, likely …
ViiV Healthcare shows long-acting regimens may improve convenience, adherence, and satisfaction for people living with HIV
First 16-week data from the APEX Part A trial reveal APG777 could raise the bar for biologics in …
SUMMIT trial shows bezuclastinib reduces symptom burden and mast cell markers significantly in non-advanced systemic mastocytosis
In the VERIFY study rusfertide demonstrated both safety and efficacy in reducing phlebotomy dependence for patients with polycythemia …
A new international trial aims to confirm the benefit of adding masitinib to chemotherapy in men with metastatic …
Hope rises for patients with relapsed or refractory acute myeloid leukemia carrying the NPM1 mutation as revumenib moves …
